Entero Therapeutics Inc (ENTO)

Feb 03, 2025

AzurRx BioPharma Announces Results of Phase IIa Trial of MS1819-SD in Exocrine Pancreatic Insufficiency - Marketscreener.com

Feb 03, 2025

Jan 14, 2025

Entero Therapeutics faces Nasdaq delisting over meeting lapse By Investing.com - Investing.com Australia

Jan 14, 2025

Jan 13, 2025

Entero Therapeutics faces Nasdaq delisting over meeting lapse - Investing.com

Jan 13, 2025

Jan 08, 2025

Entero therapeutics CFO sells $465 in stock - Investing.com

Jan 08, 2025

Dec 07, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SUM, STAF, ALVR, ENTO on Behalf of Shareholders - The Malaysian Reserve

Dec 07, 2024

Dec 06, 2024

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of SUM, ENTO, ALVR and STAF - GlobeNewswire Inc.

Dec 06, 2024

Dec 04, 2024

ENTO (Entero Therapeutics) Price-to-Operating-Cash-Flow : (As of Dec. 04, 2024) - GuruFocus.com

Dec 04, 2024

Dec 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Dec 04, 2024

Dec 04, 2024

First Wave BioPharma, Inc. announced that it expects to receive $4 million in funding - Marketscreener.com

Dec 04, 2024

Nov 29, 2024

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead - News & Insights

Nov 29, 2024

Nov 28, 2024

Entero Therapeutics faces financial obligations acceleration By Investing.com - Investing.com Nigeria

Nov 28, 2024

Nov 28, 2024

Entero Therapeutics faces financial obligations acceleration - Investing.com India

Nov 28, 2024

Nov 27, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAF, ATSG, ENTO, AVTE on Behalf of Shareholders - Marketscreener.com

Nov 27, 2024

Nov 22, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve

Nov 22, 2024

Nov 21, 2024

Finansavisen - Finansavisen

Nov 21, 2024

Nov 19, 2024

Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - PR Newswire

Nov 19, 2024

Nov 16, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

Nov 16, 2024

Nov 15, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - AccessWire

Nov 15, 2024

Nov 14, 2024

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc.ENTO - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum - The Manila Times

Nov 14, 2024

Nov 14, 2024

Entero Therapeutics announces proposed reverse merger with Journey Therapeutics - TipRanks

Nov 14, 2024

Nov 14, 2024

Entero finds lifeline in reverse merger with nano-immunoconjugate firm Journey - FirstWord Pharma

Nov 14, 2024

Nov 13, 2024

Ademi LLP Investigates Whether Entero Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Nov 13, 2024

Nov 13, 2024

Shareholder Alert: Ademi LLP Investigates Whether Entero Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - The Bakersfield Californian

Nov 13, 2024

Nov 13, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve

Nov 13, 2024

Nov 13, 2024

ENTO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Entero Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Nov 13, 2024

Nov 13, 2024

Entero, Journey to merge, creating oncology-focused biopharma By Investing.com - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

Journey Therapeutics, Inc. entered into a binding term sheet to acquire Entero Therapeutics, Inc. in a reverse merger transaction. - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Entero stock in focus amid reverse merger plans (ENTO:NASDAQ) - Seeking Alpha

Nov 13, 2024

Nov 13, 2024

Entero, Journey to merge, creating oncology-focused biopharma - Investing.com

Nov 13, 2024

Nov 13, 2024

Entero Therapeutics Announces Proposed Reverse Merger with - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Entero Therapeutics Announces 99% Reverse Merger Deal with Journey's Cancer Platform | ENTO Stock News - StockTitan

Nov 13, 2024

Nov 03, 2024

FIRST WAVE BIOPHARMA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Nov 03, 2024

Nov 02, 2024

AzurRx BioPharma, Inc. Adds Two New Clinical Trial Sites in Europe for Phase 2b OPTION 2 Extension Study of MS1819 Immediate-Release Capsules in Cystic Fibrosis Patients - Marketscreener.com

Nov 02, 2024

Oct 30, 2024

AzurRx BioPharma Announces First Two Patients Dosed in Phase 2b OPTION 2 Extension Study of MS1819 in Cystic Fibrosis Patients - Marketscreener.com

Oct 30, 2024

Oct 25, 2024

Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace

Oct 25, 2024

Oct 16, 2024

How Are Things Looking For Entero Therapeutics Inc. (NASDAQ: ENTO) For The Short Term? - Stocks Register

Oct 16, 2024

Oct 11, 2024

Entero therapeutics CFO sells shares to cover tax obligations By Investing.com - Investing.com South Africa

Oct 11, 2024

Oct 11, 2024

Entero therapeutics CFO sells shares to cover tax obligations - Investing.com India

Oct 11, 2024

Oct 09, 2024

Entero Therapeutics Inc.’s Market Journey: Closing Weak at 0.42, Down -19.41 - The Dwinnex

Oct 09, 2024

Oct 08, 2024

Taking on analysts’ expectations and winning: Entero Therapeutics Inc. (ENTO) - SETE News

Oct 08, 2024

Oct 07, 2024

Potential Price Increase for Entero Therapeutics Inc. (ENTO) After Recent Insider Activity - Knox Daily

Oct 07, 2024

Oct 07, 2024

Market cap of Entero Therapeutics Inc. [ENTO] reaches 1.95M – now what? - The DBT News

Oct 07, 2024